Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: patient recorded as having no known allergies to drugs attending: chief complaint: chest pain and shortness of breath. major surgical or invasive procedure: intubation pulmonary artery catheter left triple lumen catheter radial artery catheter cardiac catheterization () brief hospital course: hospital course beginning : -chf decompensation: pt has continued to diurese well in the unit. he was maintained on a combination of dobutamine, nesiritide, and lasix drips, prompting about one to two liters negative per day. as the pt was thought to be near dry weight, he was weaned off nesiritide, maintained on lasix and dobutamine. at this point, the heart failure service was consulted to arrange for outpatient followup. their impression was that he would benefit from further diuresis. mr. was changed to milrinone with lasix drip, also promoting good diuresis. throughout this course the pt had difficulty tolerating doses of captopril exceeding 6.25; bp would drop to the 80's and pt would become fatigued. on milrinone, pt's cardiac output was around 4.8-5.0 and index was 2.8-3.2. pt was eventually weaned from milrinone on while ace was increased. pt was diuresed on lasix drip until lisinopril was slowly added. he was transferred to the cardiology floor for continued diuresis, and was started on bumex 3mg po qd. he continued to diurese well on bumax until dc, with bp remaining stable in the high 80s to low 90s. at dc, he had been diuresed >18l since admission; he is below his estimated dry weight of 170 pounds; peripheral edema was markedly inproved and he appeared euvolemic. -cad: pt underwent cath as part of transplant evaluation that demonstrated an 80% mid-lad restenosis (treated with brachytherapy) and lesions throughout lcx, including a 40% proximal (taxus stent placed), 70% mid (taxus placed), and 60% distal (two bare metal stents placed). he was medically managed with asa, statin, zetia, and ace-i. pt has shown no active ischemia during his admission. -rhythm: pt continued to experience pvc's and rare runs of nsvt in the ccu (no greater than 10-15 beats). the nsvt, however, usually appeared at points where pt's dofetilide was decreased because of increasing creatinine. on dofetilide, pt rarely had any episodes of nsvt. after transfer to the cardiology floor, he exhibited no nsvt on dofetilide therapy. -resp: pt has maintained good saturations on nc. he temporarily developed sats into the low 90's on 2l, had to be turned up to 5l, but subsequently improved until he was not requiring o2 except occasionally during sleep. -gi: pt has h/o unworked up gi bleed, and is probably main source of anemia. it is not an acute problem, and hct usually does not drop more than 4-5% every few days. pt will require an outpatient colonoscopy. -renal: pt experienced intermittent increases in cr from baseline of near 1.0 up to 1.5, usually after agressive diuresis. these elevations would resolve quickly and were thought to be secondary to a prerenal etiology. he is at baseline renal fxn at dc. -heme: pt remains anemic, usually stable around a hct of 30-31, however he occasionally drops to 28 and has recieved unit transfusions at these times. in an attempt to limit transfusion frequency, pt was placed on epogen. -id: pt remains afebrile, without increased white count. pt is s/p treatment for pneumonia, and this seems to have resolved. at dc, he has no signs or symptoms of infection. -endocrine: pt's blood glc and hgba1c indicate dm, although diabetes must not be diagnosed by glucose levels during periods of acute stress. blood glucose was well controlled on sliding scale insulin in the ccu; on the cardiology floor, he did not require insulin to control bg, making a diagnosis of dm less likely. he will be dc without glucose controlling agents, and will require early f/u to evaluate for dm. pt's tft's showed elevated tsh but a therapeutic free t4 on 75mcg of levothyroxine; he remained stable on his oupatient levothyroxine dose. discharge medications: 1. outpatient lab work will need chem 10 done on 2. outpatient lab work will need pt/ptt/inr done on 3. atorvastatin calcium 40 mg tablet sig: one (1) tablet po qd (once a day). disp:*30 tablet(s)* refills:*2* 4. levothyroxine sodium 75 mcg tablet sig: one (1) tablet po qd (once a day). disp:*30 tablet(s)* refills:*2* 5. aspirin 325 mg tablet, delayed release (e.c.) sig: one (1) tablet, delayed release (e.c.) po qd (once a day). disp:*30 tablet, delayed release (e.c.)(s)* refills:*2* 6. lisinopril 5 mg tablet sig: one (1) tablet po bid (2 times a day). disp:*60 tablet(s)* refills:*2* 7. bumetanide 1 mg tablet sig: three (3) tablet po bid (2 times a day). disp:*180 tablet(s)* refills:*2* 8. clopidogrel bisulfate 75 mg tablet sig: one (1) tablet po qd (once a day). disp:*30 tablet(s)* refills:*2* 9. ezetimibe 10 mg tablet sig: one (1) tablet po qd (once a day). disp:*30 tablet(s)* refills:*2* 10. carbidopa-levodopa 25-100 mg tablet sig: one (1) tablet po qid (4 times a day). disp:*120 tablet(s)* refills:*2* 11. sodium chloride 0.65 % aerosol, spray sig: sprays nasal tid (3 times a day) as needed. disp:*1 1* refills:*0* 12. docusate sodium 100 mg capsule sig: one (1) capsule po bid:prn as needed for constipation for 1 months. disp:*60 capsule(s)* refills:*0* 13. metoprolol succinate 25 mg tablet sustained release 24hr sig: 0.5 tablet sustained release 24hr po qd (once a day). disp:*15 tablet sustained release 24hr(s)* refills:*2* 14. warfarin sodium 7.5 mg tablet sig: one (1) tablet po hs (at bedtime) for 1 months. disp:*30 tablet(s)* refills:*0* 15. ipratropium bromide 18 mcg/actuation aerosol sig: two (2) puff inhalation qid (4 times a day). disp:*1 1* refills:*2* 16. epoetin alfa 4,000 unit/ml solution sig: one (1) 4000u/ml injection 3x/week (mo,we,fr). disp:*12 4000u/ml* refills:*2* 17. tylenol-codeine #3 300-30 mg tablet sig: 1-2 tablets po at bedtime as needed for pain. disp:*30 tablet(s)* refills:*0* 18. dofetilide 250 mcg capsule sig: one (1) capsule po twice a day. disp:*60 capsule(s)* refills:*2* discharge disposition: home with service facility: vna discharge diagnosis: nstemi chf with ef 20% (dry weight~170) respiratory failure acute pulmonary edema hyponatremia anemia cad nsvt diabetes mellitus hypothyroidism multiple sclerosis discharge condition: stable to home with pt services. discharge instructions: please take all your medications and follow up with all your recommended appointments. please seek medical attention if you develop chest pain, worsening shortness or breath, fevers, chills, nausea/vomiting, increasing lower extremity edema followup instructions: 1. please follow up with your primary care physician . within 2 weeks. please call to schedule an appointment at . 2. please follow up with dr. from the heart failure department within 2 weeks. please call to schedule an appointment at . 3. please follow up with dr. from the heart transplant deparment at . please call to schedule an appointment. 4. please ask your primary care physician to recommend gastroenterologist to follow up with. you will likely need a colonoscopy to evaluate the cause of your anemia. also follow-up with primary care regarding diabetes management evaluation, as you were hypoglycemic in hospital but likely do not have diabetes. 5. please follow-up with neurologist dr. within 1 month regarding therapy for muscle spasms. md procedure: continuous invasive mechanical ventilation for less than 96 consecutive hours venous catheterization, not elsewhere classified combined right and left heart cardiac catheterization coronary arteriography using two catheters coronary arteriography using two catheters angiocardiography of left heart structures injection or infusion of platelet inhibitor left heart cardiac catheterization transfusion of packed cells injection or infusion of nesiritide insertion of drug-eluting coronary artery stent(s) diagnoses: pneumonia, organism unspecified congestive heart failure, unspecified acute kidney failure, unspecified iron deficiency anemia secondary to blood loss (chronic) hyposmolality and/or hyponatremia paroxysmal ventricular tachycardia acute respiratory failure cardiogenic shock hemorrhage of gastrointestinal tract, unspecified 

Answer: The patient is high likely exposed to